Literature DB >> 12616685

Diagnosis and treatment of neurotransmitter-related disorders.

Kathryn J Swoboda1, Keith Hyland.   

Abstract

Neurotransmitter disorders constitute a spectrum of neurologic conditions that share several clinical features depending on the severity and pattern of neurotransmitter deficiency or excess. These uncommon conditions can be suspected based on their clinical features, and several can be confirmed by cerebrospinal fluid analysis of neurotransmitters and their metabolites. Certain disorders, such as autosomal dominant dopa-responsive dystonia caused by GTP cyclohydrolase deficiency, or Segawa syndrome, respond dramatically to medical therapy. This article summarizes current knowledge regarding the clinical manifestations, diagnosis, and treatment of these important disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12616685     DOI: 10.1016/s0733-8619(02)00018-x

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  9 in total

1.  Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.

Authors:  Michael A Thomas; Parag P Joshi; Rebecca D Klaper
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-06-06       Impact factor: 3.228

Review 2.  The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasis.

Authors:  Hannah C Kinney; Kevin G Broadbelt; Robin L Haynes; Ingvar J Rognum; David S Paterson
Journal:  J Chem Neuroanat       Date:  2011-05-27       Impact factor: 3.052

Review 3.  Update on the pathology of dystonia.

Authors:  David G Standaert
Journal:  Neurobiol Dis       Date:  2011-01-08       Impact factor: 5.996

4.  Diagnosis and treatment of neurotransmitter disorders.

Authors:  Phillip L Pearl; Thomas R Hartka; Jacob Taylor
Journal:  Curr Treat Options Neurol       Date:  2006-11       Impact factor: 3.598

5.  Uncovering the genetic profiles underlying the intrinsic organization of the human cerebellum.

Authors:  Yaping Wang; Lin Chai; Congying Chu; Deying Li; Chaohong Gao; Xia Wu; Zhengyi Yang; Yu Zhang; Junhai Xu; Jens Randel Nyengaard; Simon B Eickhoff; Bing Liu; Kristoffer Hougaard Madsen; Tianzi Jiang; Lingzhong Fan
Journal:  Mol Psychiatry       Date:  2022-03-09       Impact factor: 13.437

Review 6.  Increasing physical function through physiatric intervention for children with paediatric neurotransmitter disorders.

Authors:  S Evans; K Forester; J M Pettiford; O Morozova
Journal:  J Inherit Metab Dis       Date:  2009-05-17       Impact factor: 4.982

7.  Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study.

Authors:  Saadet Mercimek-Mahmutoglu; Sarah Sidky; Keith Hyland; Jaina Patel; Elizabeth J Donner; William Logan; Roberto Mendoza-Londono; Mahendranath Moharir; Julian Raiman; Andreas Schulze; Komudi Siriwardena; Grace Yoon; Lianna Kyriakopoulou
Journal:  Orphanet J Rare Dis       Date:  2015-02-08       Impact factor: 4.123

8.  Kaempferia parviflora rhizome extract and Myristica fragrans volatile oil increase the levels of monoamine neurotransmitters and impact the proteomic profiles in the rat hippocampus: Mechanistic insights into their neuroprotective effects.

Authors:  Waluga Plaingam; Siriporn Sangsuthum; Wannee Angkhasirisap; Tewin Tencomnao
Journal:  J Tradit Complement Med       Date:  2017-06-15

9.  Dopa-Responsive Dystonia in Han Chinese Patients: One Novel Heterozygous Mutation in GTP Cyclohydrolase 1 (GCH1) and Three Known Mutations in TH.

Authors:  Kunfang Yang; Rongrong Yin; Xiaoping Lan; Yuanfeng Zhang; Hongyi Cheng; Simei Wang; Chunmei Wang; Yanfen Lu; Jiaming Xi; Qin Lu; Jianjun Huang; Yucai Chen
Journal:  Med Sci Monit       Date:  2018-02-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.